The Center for Business Intelligence (CBI) is pleased to announce Preclinical and Clinical Imaging for Drug Development being held February 23, 2011 from 9:30 a.m. - 6:00 p.m. EST. CBI provides an opportunity to bring together a diverse collection of imaging experts from around the world to discuss the latest imaging technologies relevant to today's practitioners in a virtual conference environment.
This inaugural virtual conference will provide insights and practical information on the latest developments affecting this rapidly evolving field. This conference offers an understanding of the importance of R&D into novel therapies and discusses the application of current and innovative imaging technologies and developments in oncology, CNS and cardiovascular therapeutic areas. This conference will also examine the importance of translational studies and how to bridge the preclinical to clinical divide while emphasizing how to develop and incorporate imaging solutions that lead to earlier diagnosis.
Confirmed speakers include:
CBI is a subsidiary of Advanstar Communications Inc., and develops market-driven, unbiased conferences in the fields of pharmaceuticals and biotech, medical devices, and managed care markets. Applied Clinical Trials is also owned by Advanstar Communications Inc.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.